Diclofenac-K (50 and 100 mg) and placebo in the acute treatment of migraine (pages 117–123)C Dahlöf and R Björkman, For the Finnish-Swedish Oral Diclofenac-K Study Group: H Kilpelainen, K Koivisto, K Murros, K Reinikainen, M Saksa, P Andersson
Article first published online: 19 JAN 2002 | DOI: 10.1046/j.1468-2982.1993.1302117.x